Impact of real-time notification of Clostridium difficile test results and early initiation of effective antimicrobial therapy

American Journal of Infection Control

Volumn 46, Issue 5, 2018, Pages 538-541

  Polen, Christian B ^a   Judd, William R ^a   Ratliff, Patrick D ^a   King, Gregory S ^a  

^a Saint Joseph Hospital Lexington   (United States)

Author keywords

antimicrobial stewardship program; Clostridium difficile; early initiation; infection prevention; time to effective therapy

Indexed keywords

ANTIBIOTIC AGENT; METRONIDAZOLE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIMICROBIAL STEWARDSHIP; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM DETECTION; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE NOTIFICATION; ELECTRONIC MEDICAL RECORD; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; KENTUCKY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PHARMACIST; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; VERY ELDERLY; CLOSTRIDIUM INFECTION; CROSS INFECTION; EARLY DIAGNOSIS; HEALTH SERVICES RESEARCH; ISOLATION AND PURIFICATION; MOLECULAR DIAGNOSIS; ORGANIZATION AND MANAGEMENT; SECONDARY PREVENTION; TERTIARY CARE CENTER; TIME FACTOR;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL STEWARDSHIP; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; EARLY DIAGNOSIS; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; KENTUCKY; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; TERTIARY CARE CENTERS; TIME FACTORS;

EID: 85039868329     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2017.11.010     Document Type: Article

References (13)

1. Leffler, D.A., Lamont, J.T., Clostridium difficile infection. N Engl J Med 372 (2015), 1539–1548.
2. Voth, D.E., Ballard, J.D., Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 18 (2005), 247–263.
3. Lessa, F., Mu, Y., Bamberg, W., Beldavs, Z.G., Dumyati, G.K., Dunn, J.R., et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 372 (2015), 825–834.
4. CDC, Antibiotic resistance threats in the United States. 2013, US Department of Health and Human Services, CDC, Atlanta (GA).
5. Dubberke, E.R., Olsen, M.A., Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 55:Suppl (2012), S88–S92.
6. Valiquette, L., Cossette, B., Garant, M.P., Diab, H., Pepin, J., Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 45:Suppl (2007), S112–S121.
7. Carling, P., Fung, T., Killion, A., Terrin, N., Barza, M., Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 24 (2003), 699–706.
8. Cohen, S.H., Gerding, D.N., Johnson, S., Kelly, C.P., Loo, V.G., McDonald, L.C., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 31 (2010), 431–455.
9. McFarland, L.V., Mulligan, M.E., Kwok, R.Y., Stamm, W.E., Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 320 (1989), 204–210.
10. Muto, C.A., Blank, M.K., Marsh, J.W., Vergis, E.N., O'Leary, M.M., Shutt, K.A., et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive “bundle” approach. Clin Infect Dis 45 (2007), 1266–1273.
11. Fowler, S., Webber, A., Cooper, B.S., Phimister, A., Price, K., Carter, Y., et al. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. J Antimicrob Chemother 59 (2007), 990–995.
12. Ferrer, R., Martin-Loeches, I., Phillips, G., Osborn, T.M., Townsend, S., Dellinger, R.P., et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 42 (2014), 1749–1755.
13. Kumar, A., Roberts, D., Wood, K.E., Light, B., Parrillo, J.E., Sharma, S., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34 (2006), 1589–1596.